Literature DB >> 3103666

Effect of posture on glyceryl trinitrate plasma concentrations following transdermal application.

R Heidemann, C Beckenbauer, B G Woodcock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103666      PMCID: PMC1386078          DOI: 10.1111/j.1365-2125.1987.tb03039.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Influence of posture on plasma nitroglycerin.

Authors:  S H Curry; H R Kwon
Journal:  Br J Clin Pharmacol       Date:  1985-03       Impact factor: 4.335

2.  [Serum concentration of glyceryl trinitrate (GTN) in transdermal application of GTN dressings of various origins].

Authors:  R Heidemann; G Menke; H Letzel; N Rietbrock
Journal:  Dtsch Med Wochenschr       Date:  1985-10-11       Impact factor: 0.628

  2 in total
  6 in total

1.  Novel pharmacokinetic modelling of transdermal nitroglycerin.

Authors:  B Auclair; G Sirois; A H Ngoc; M P Ducharme
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

2.  Influence of exercise on nitroglycerin plasma concentrations after transdermal application.

Authors:  R A Lefebvre; M G Bogaert; O Teirlynck; A Sioufi; J P Dubois
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

Review 3.  Transdermal nitroglycerin (glyceryl trinitrate). A review of its pharmacology and therapeutic use.

Authors:  P A Todd; K L Goa; H D Langtry
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.

Authors:  Satoru Hashimoto; Atsuko Kobayashi
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of nitrates.

Authors:  M G Bogaert
Journal:  Cardiovasc Drugs Ther       Date:  1994-10       Impact factor: 3.727

6.  Transdermal nitrate therapy: bioavailability during exercise increases transiently after the daily change of patch.

Authors:  K Gjesdal; T O Klemsdal; E O Rykke; J E Bredesen
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.